[1] |
Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong.
Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424.
|
[2] |
Zhang Hongtai, Ren Yixuan, Hu peilei, Wang Nenhan, Li Jie, Tian Lili, Zhao Yanfeng, Chen Shuangshuang, Li Chuanyou.
Comparison of microbiota diversity in the sputum of pulmonary tuberculosis patients with rifampicin resistance or sensitivity
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 625-633.
|
[3] |
Gulina Badeerhan, Liu Nianqiang, Yipaer Aihaiti, Wang Le, Wang Senlu, Zulikatiayi Abudula, Wang Mingzhe, Zhang Jing, Wang Xinqi, Bi Hongbo.
The effect of GeneXpert MTB/RIF detection technology in tuberculosis prevention and control program in Xinjiang
[J]. Chinese Journal of Antituberculosis, 2024, 46(2): 173-177.
|
[4] |
Ruan Yunzhou, Su Wei, Zhang Hui, Zhao Yanlin.
Historical evolution and prospect of rifampicin-resistant tuberculosis prevention and control in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1166-1170.
|
[5] |
Li Jing, Jiang Qi, Jiang Yuan, Shen Xin.
Evaluation of performance of PCR fluorescent probe method for detecting Mycobacterium tuberculosis complex and rifampicin resistance
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1250-1258.
|
[6] |
Liu Mei, Wu Xia, Gu Xu, Li Nana, Zhang Wanmin, Zhang Xiaoke, Lan Yuanbo.
Evaluation of the performance of InnowaveDX MTB/RIF in detecting Mycobacterium tuberculosis complex and rifampicin resistance
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 70-74.
|
[7] |
Lyu Tong, Yang Yunbin, Pan Ying, Cheng Yuyu, Li Zichao, Xu Lin.
Analysis of economic burden and influencing factors of rifampin-resistant pulmonary tuberculosis in Yunnan Province
[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1031-1037.
|
[8] |
Chen Daiquan, Lin Shufang, Dai Zhisong, Zhou Yinfa, Chen Kun.
Construction and validation of a nomogram for predicting unfavorable treatment outcomes among patients with rifampicin-sensitive tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(10): 957-966.
|
[9] |
WU Bo, LIU Ying, LIAO Wen-pin, ZHENG Yi, QIN Bo, YANG Jing, XIE Hui-man, YU Ya.
Analysis of economic burden of pulmonary tuberculosis patients in four districts and counties of Chongqing
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 390-396.
|
[10] |
WANG Wei, YE Yi-nong, LIN Dong-zi, ZHONG Qian-hong, HUANG Fei, DU Fang-fang, CHENG Shi-ming, ZHOU Jie, ZHANG Xi-lin, ZHONG Qiu.
Analysis of epidemiological characteristics of rifampicin resistance tuberculosis in Foshan City, Guangdong Province, 2011-2020
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 187-192.
|
[11] |
YANG Xiao-li, HE Bing, WANG Jiao-lei, ZHANG Yun-yun, ZHANG Chun-xia, LI Yue, LI Jian-jun, SHI Wen-tao.
Diagnostic value of GeneXpert MTB/RIF in detecting patients with coal workers’ pneumoconiosis complicated with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 821-825.
|
[12] |
CHANG Jun-li, ZHANG Jian-hong, ZHANG Ying, ZHANG Hai-fang, FAN Peng-fei, LI Qiu-hua, DING Xue-ling.
Investigation and analysis of a cluster epidemic of rifampicin-resistant tuberculosis in a school
[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 751-754.
|
[13] |
SHU Wei, GE Qi-ping, HUANG Xue-rui, MA Li-ping, JI Bin-ying, CHEN Yu-hui, CHEN Xiao-you, JIANG Guang-lu, XIE Li, LI Bo, CHEN Sheng-yu, CHEN Sen-lin, YAN Jun-ping, SHI Lian, CHEN Ling, LI You-lun, XI Xiu-e, LIU Qian-ying, YAN Xing-lu, WANG Fei, WANG Fu-rong, WU Xiang, ZHANG Peng, LENG Xue-yan, CAO Wen-li, ZHANG Hai-qing, CUI Hong-zhe, YANG Cheng-qing, WU Chao, LI Juan, LI Hua, SUN Yu-xian, ZHANG Li-jie, XIE Shi-heng, NING Yu-jia, TIAN Xi-zhong, DU Jian, LI Liang, GAO Wei-wei.
Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 322-327.
|
[14] |
WANG Xi-jiang, TAN Yun-hong, HE Wen-cong, OU Xi-chao, LIU Dong-xin, ZHAO Yan-lin.
The correlation between rifampicin and isoniazid resistance-related gene mutations and resistance level in Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 248-254.
|
[15] |
LI Ren-zhong, RUAN Yun-zhou, SU Wei, HE Yu-ying, LIU Kuang-yi.
Interpretation of Rifampicin-resistant pulmonary tuberculosis diagnostic process
[J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1113-1115.
|